Allergan gets DoJ subpoena over generic drug pricing
 

Allergan gets DoJ subpoena over generic drug pricing
(Reuters) - Allergan Plc said on Thursday it received a subpoena from the U.S. Department of Justice seeking information on marketing and pricing of its generic *****.


http://rc.feedsportal.com/r/23456681...21/rc/1/rc.img

http://rc.feedsportal.com/r/23456681...21/rc/2/rc.img

http://rc.feedsportal.com/r/23456681...21/rc/3/rc.img

http://da.feedsportal.com/r/23456681...2/sc/21/a2.img
http://adchoice.feedsportal.com/r/23.../sc/21/ach.imghttp://pi.feedsportal.com/r/23456681.../sc/21/a2t.imghttp://pi2.feedsportal.com/r/2345668...sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...4c:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...4c:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/jHmd2Id-Ls4